These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2429164)

  • 21. Comparison of the drug metabolising ability of rat intestinal mucosal microsomes with that of liver.
    Shirkey RS; Chakraborty J; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2835-9. PubMed ID: 497032
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
    Gunasena GH; Kanz MF
    J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation of cholesterol in vitro into rat liver microsomal fractions from serum and its effect on cytochrome P-450-dependent hydroxylation [proceedings].
    Rae PW; Blair HA; Boyd GS; Suckling KE
    Biochem Soc Trans; 1980 Feb; 8(1):122-3. PubMed ID: 7371914
    [No Abstract]   [Full Text] [Related]  

  • 24. Diphasic action of the aliphatic amide, HOE 17879, on hepatic microsomal drug metabolizing enzymes in the mouse.
    Beyhl FE; Lindner E
    Experientia; 1976 Mar; 32(3):362-5. PubMed ID: 176059
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential distribution of the mixed-function oxidase activities in rabbit kidney.
    Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1978 Dec; 207(3):719-25. PubMed ID: 731427
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The destruction of pulmonary and hepatic cytochrome P-450 by phthaladehyde.
    Patel JM
    Toxicol Appl Pharmacol; 1979 Apr; 48(2):337-42. PubMed ID: 473183
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of the hepatic cytochrome P-450-dependent monooxygenase system by rubratoxin B in male mice.
    Siraj MY; Hayes AW
    Toxicol Appl Pharmacol; 1979 May; 48(3):351-9. PubMed ID: 582484
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic drug metabolism in rats: impairment in a dirty environment.
    Vesell ES; Lang CM; White WJ; Passananti GT; Tripp SL
    Science; 1973 Mar; 179(4076):896-7. PubMed ID: 4687785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pesticide-induced changes in hepatic microsomal enzyme systems. Some effects of 1,1-di(p-chlorophenyl)-2,2-dichloroethylene (DDE) and 1,1-di(p-chlorophenyl)-2-chloroethylene (DDMU) in the rat and Japanese quail.
    Bunyan PJ; Page JM
    Chem Biol Interact; 1973 Apr; 6(4):249-57. PubMed ID: 4704124
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hymenoxon: biologic and toxic effects.
    Merrill J; Kim H; Safe S
    Biochem Pharmacol; 1985 Sep; 34(18):3383-6. PubMed ID: 4038346
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADPH-dependent mono-oxidase system of hepatic microsomes.
    Mannering GJ; Kuwahara S; Omura T
    Biochem Biophys Res Commun; 1974 Mar; 57(2):476-81. PubMed ID: 4151403
    [No Abstract]   [Full Text] [Related]  

  • 34. Covalent binding in vitro of polychlorinated biphenyls to microsomal macromolecules. Involvement of metabolic activation by a cytochrome P-450-linked mono-oxygenase system.
    Shimada T; Sato R
    Biochem Pharmacol; 1978 Feb; 27(4):585-93. PubMed ID: 204312
    [No Abstract]   [Full Text] [Related]  

  • 35. Perinatal drug metabolism and morphological changes in the hepatocytes of normal and phenobarbital-treated guinea pigs.
    Kuenzig W; Kamm JJ; Boublik M; Jenkins F; Burns JJ
    J Pharmacol Exp Ther; 1974 Oct; 191(1):32-44. PubMed ID: 4153895
    [No Abstract]   [Full Text] [Related]  

  • 36. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
    Duescher RJ; Elfarra AA
    Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cytochrome P450IIE1 in bioactivation of acetaminophen in diabetic and acetone-treated mice.
    Jeffery EH; Arndt K; Haschek WM
    Adv Exp Med Biol; 1991; 283():249-51. PubMed ID: 2068990
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of the mixed function oxidase system of rat hepatic microsomes to parathion and malathion and their oxygenated analogs.
    Stevens JT; Greene FE
    Life Sci; 1973 Dec; 13(12):1677-91. PubMed ID: 4149666
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for an inhibitory product-cytochrome P-450 complex generated during benzphetamine metabolism by liver microsomes.
    Werringloer J; Estabrook RW
    Life Sci; 1973 Nov; 13(10):1319-30. PubMed ID: 4148650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.